(Q44264029)

1 December 2017

title

Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats (English)

1 reference

1 December 2017

Andrew M Seacat

1

1 reference

1 December 2017

Peter J Thomford

2

1 reference

1 December 2017

Kris J Hansen

3

1 reference

1 December 2017

Lisa A Clemen

4

1 reference

1 December 2017

Sandra R Eldridge

5

1 reference

1 December 2017

Cliff R Elcombe

6

1 reference

1 December 2017

John L Butenhoff

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 December 2017

number of pages

15

1 reference

inferred from page(s)

published in

Toxicology

1 reference

1 December 2017

volume

183

1 reference

1 December 2017

issue

1-3

1 reference

1 December 2017

page(s)

117-131

1 reference

Possible involvement of fatty acid binding protein in peroxisomal beta-oxidation of fatty acids

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Fatty acid oxidation by human liver peroxisomes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

New Tables for Multiple Comparisons with a Control

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

The role of cell proliferation in chemically induced carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Global distribution of perfluorooctane sulfonate in wildlife.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Quantitative characterization of trace levels of PFOS and PFOA in the Tennessee River

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Accumulation of perfluorooctane sulfonate in marine mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Effects of peroxisome proliferators on fatty acid-binding protein in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Roles of PPARs in health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Comparative studies on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation in the rat and hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Assay of peroxisomal beta-oxidation of fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Interactions of fluorochemicals with rat liver fatty acid-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Monoclonal antibodies against proliferating cell nuclear antigen cross-react with the peroxisomal multifunctional protein

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Structural determinants of fluorochemical-induced mitochondrial dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

Suppression of clofibrate-induced peroxisome proliferation in rat liver by nicardipine, a calcium antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900511-5

7 January 2021

10.1016/S0300-483X(02)00511-5

Identifiers

DOI

1 reference

1 December 2017

1 reference